Delivery Order SPE2DB24D3015-SPE2DB24FFXVT
Award Date
9/18/24
Potential Completion Date
10/9/24
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of IMBRUVICA 420 MG TABLET 28S. The $7,322.67 contract has an ultimate completion date of October 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which allows the government to efficiently procure a...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a total ceiling value of $7,120.23 and an ultimate completion date of October 4, 2024. This award is not set-aside and is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product IMBRUVICA 140 MG TABLET 28S. The contract, valued at $7,322.67, has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. government awarded a $7,322.67 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 280 MG TABLET 28S. This contract is a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to efficiently procure a range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a $7,845.72 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 140 mg Imbruvica capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and facilities worldwide....
The Defense Logistics Agency (DLA) awarded a $14,645.34 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to supply 4565827989 IMBRUVICA 420 MG TABLET 28S. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen,...
This is a delivery order worth $7,322.67 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price and a delivery order contract type, with a period of performance ending on September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these pharmaceutical products to support federal healthcare programs and initiatives. The contract is not set aside and is part of a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of IMBRUVICA 420 mg tablets to support military and government healthcare programs. The $7,575.75 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division for the provision of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has a ceiling value of $7,322.67 and an ultimate completion date of May 7, 2024. This is not a set-aside contract. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a $88,618.20 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 280 MG TABLET 28S. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999.00, which provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not...